Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BibbInstruments ABFRA:V0R +4.17%23 PB Ratio is 1.08 as of Jul. 30, 2026, which is 72% below its 10-year median of 3.79. GuruFocus rates FRA:V0R with a GF Score™ of 23/100. The stock has 2 warning signs investors should review. Among 787 Medical Devices & Instruments companies, BibbInstruments AB ranks better than 70.65% on this metric.
The historical rank and industry rank for BibbInstruments AB's PB Ratio or its related term are showing as below:
FRA:V0R'
s PB Ratio Range Over the Past 10 Years
Min: 0.69 Med: 3.79 Max: 8.56
Current: 1.25
During the past 11 years, BibbInstruments AB's highest PB Ratio was 8.56. The lowest was 0.69. And the median was 3.79.
FRA:V0R's PB Ratio is ranked better than 70.65% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.04
vs FRA:V0R: 1.25
During the past 12 months, BibbInstruments AB's average Book Value Per Share Growth Rate was -32.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -9.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.90% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 23.10% per year.
During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of BibbInstruments AB was 346.60% per year. The lowest was -28.60% per year. And the median was -5.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
BibbInstruments AB PB Ratio Related Terms
BibbInstruments AB PB Ratio Historical Data
* Premium members only.
The historical data trend for BibbInstruments AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BibbInstruments AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BibbInstruments AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BibbInstruments AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where BibbInstruments AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
BibbInstruments AB (FRA:V0R) has a PB Ratio of 1.08 as of Jul. 30, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BibbInstruments AB and its competitors. This is 72% below median its historical median of 3.79. Over the past decade, BibbInstruments AB's PB Ratio has ranged from 0.69 to 8.56. According to the industry distribution chart, BibbInstruments AB ranks #231 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 29.4%.
Is BibbInstruments AB's PB Ratio too high?
BibbInstruments AB's current PB Ratio of 1.08 is 72% below median its 10-year median of 3.79. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 8.56. The Medical Devices & Instruments industry median PB Ratio is 2.04. BibbInstruments AB's value of 1.08 is 47.1% below this industry median. Based on the distribution chart, BibbInstruments AB ranks #231 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, BibbInstruments AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does BibbInstruments AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BibbInstruments AB ranks #231 out of 787 companies for PB Ratio. This puts BibbInstruments AB in the upper half of its industry. The industry median PB Ratio is 2.04. BibbInstruments AB's value of 1.08 is 47.1% below this benchmark. Historically, BibbInstruments AB's own PB Ratio has ranged from 0.69 to 8.56 over the past decade. While the company's 10-year median is 3.79 vs. the industry median of 2.04, BibbInstruments AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.04, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BibbInstruments AB's current PB Ratio of 1.08 is 47.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BibbInstruments AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BibbInstruments AB's current PB Ratio is 1.08, which is 72% below median its own 10-year median of 3.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BibbInstruments AB stock overvalued right now?
BibbInstruments AB (FRA:V0R) has a current PB Ratio of 1.08. The current PB Ratio is 1.08, which is 72% below median its 10-year median of 3.79 and 47.1% below the Medical Devices & Instruments industry median of 2.04. BibbInstruments AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For BibbInstruments AB (FRA:V0R), the current PB Ratio is 1.08 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BibbInstruments AB develops disposable biopsy instrumentation under the brand EndoDrill for early detection of cancer tumors, especially in deep-tissue tumors. The product portfolio includes six disposable instruments based on the patented EndoDrill technology and a novel biopsy method still under development. The instruments will be used for tissue sampling (biopsy) of the most common types of cancer, for example; lung, breast, colorectal, prostate and stomach cancer.
23GF Score
Get the complete analysis for FRA:V0R
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:V0R has been successfully added to your 
